drugset / Trial / NCT00654056

Severe Insulin Resistance in Patients With Type 2 Diabetes

NCT00654056

RandomizedSingle-groupSingle-blindBasic science

Summary

The purpose of the study is to investigate some of the mechanisms behind severe insulin resistance and to determine the dose response to insulin in patients with type 2 diabetes mellitus.

Timeline

Start
2008-03
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 0.5 iu/kg Other
Subject Insulin Protein / enzyme biologic 1.5 iu/kg Other
Subject Insulin Protein / enzyme biologic 3 iu/kg Other
Subject Insulin Protein / enzyme biologic 5 iu/kg Other